Welcome to the ValueWiki PDL BioPharma, Inc. (PDLI) article! Register for free or click the "edit" link to contribute!    

PDL BioPharma, Inc. (PDLI)

From ValueWiki

Jump to: navigation, search
This summary section needs content! Click Here to begin writing.
Have a question about PDL BioPharma, Inc.? Ask it on the Message Board or Chat Room
Visit the Apple, Inc. page for an example of a complete article.

Contents

Today 5d 3m 6m 1y 2y 5y Max



Funds w/ PDLI: 84
Rank: 268 / 351



Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.[1] Be bold!

News Feed

01/08/09 2:01 pm 5 Stocks Ready for Liftoff (at Motley Fool)
01/07/09 5:01 pm UPDATE - Facet Biotech to cut 80 jobs, narrow focus on oncology (at Reuters)
01/07/09 1:01 pm 4-Star Stocks on the Upswing (at Motley Fool)
01/06/09 6:01 am PDL BioPharma Announces Conversion Rate Adjustment for Its 2.00% Convertible Senior Notes Due February 15, 2012 (Marketwire)
01/05/09 12:01 pm PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)
01/05/09 8:01 am PDL BioPharma, Alexion settle patent dispute (AP)
01/05/09 7:01 am UPDATE - Alexion, PDL BioPharma settle patent dispute (at Reuters)
01/05/09 6:01 am PDL BioPharma upgraded by JP Morgan (Briefing.com)
01/05/09 6:01 am Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute (PR Newswire)
12/31/08 7:12 pm Biotech proves defensive against tough 2008 market (AP)
More News...

Risks

This section needs content! Click the blue edit link (to the right) to contribute.

Research Links

PDL BioPharma, Inc. Snapshot
PDL BioPharma, Inc. Leadership
PDL BioPharma, Inc. Fundamentals
PDL BioPharma, Inc. Technical Analysis
PDL BioPharma, Inc. Message Boards

Options

Notes

  1. This is a sample reference.
Personal tools